Download PDFPDF
19 Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a Long QT Syndrome type 2 mutation
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address